ACCELERON PHARMA INC. Additional Paid in Capital
ACCELERON PHARMA INC. had Additional Paid in Capital of $1.79 billion as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2021-11-04
- 2021-09-30: Additional Paid in Capital $1.79B.
- 2021-06-30: Additional Paid in Capital $1.77B.
- 2021-03-31: Additional Paid in Capital $1.75B.
- 2020-12-31: Additional Paid in Capital $1.73B.
| Period end | Additional Paid in Capital |
|---|---|
| 2021-09-30 | $1.79B 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.77B 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.75B 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.73B 10-Q · filed 2021-11-04 |
| 2020-09-30 | $1.72B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.20B 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.18B 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.16B 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.15B 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.14B 10-Q · filed 2019-08-05 |
| 2019-03-31 | $1.14B 10-Q · filed 2019-05-09 |
| 2018-12-31 | $879.10M 10-K · filed 2020-02-27 |
| 2018-09-30 | $871.64M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $858.58M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $850.60M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $839.09M 10-K · filed 2019-02-27 |
| 2017-09-30 | $803.91M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $608.49M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $598.66M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $590.47M 10-K · filed 2018-02-27 |
| 2016-09-30 | $574.83M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $568.00M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $562.63M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $416.93M 10-K · filed 2017-03-01 |
| 2015-09-30 | $412.17M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $407.97M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $403.96M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $399.83M 10-K · filed 2016-02-25 |
| 2014-09-30 | $393.55M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $387.79M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $381.87M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $250.11M 10-K · filed 2015-03-02 |
| 2013-09-30 | $248.75M 10-Q · filed 2013-11-14 |